ACP

Acuta Capital Partners Portfolio holdings

AUM $86.2M

AUM

$86.2M

AUM Growth

-$13.2M (-13%)

Cap. Flow

+$18.5M

Cap. Flow % of AUM

21.45%

Top 10 Holdings %Top 10 Hldgs %

64.54%

Holding

New

Increased

Reduced

Closed

1	Soleno Therapeutics SLNO	$4.8M
2	WHWK Whitehawk Therapeutics, Inc. Common Stock WHWK	$2.78M
3	Oculis Holding OCS	$2.38M
4	Merck MRK	$2.06M
5	Surrozen SRZN	$1.98M

1	Revolution Medicines RVMD	$1.59M
2	Rocket Pharmaceuticals RCKT	$341K
3	DRUG Bright Minds Biosciences DRUG	$338K
4	Terns Pharmaceuticals TERN	$337K
5	Edgewise Therapeutics EWTX	$48.5K

1	Healthcare	97.53%
2	Financials	2.45%

#	Name	Market Value	Portfolio Weight	Shares or Principal	Shares Change %	Capital Flow
26	26 Zymeworks ZYME $809M	$815K	0.95%	68,459 +1,219	+2%	+$14.5K
27	27 Ultragenyx Pharmaceutical RARE $3.35B	$771K	0.89%	21,290 +290	+1%	+$10.5K
28	28 Verve Therapeutics VERV $411M	$744K	0.86%	162,724 +2,524	+2%	+$11.5K
29	29 Rocket Pharmaceuticals RCKT $738M	$556K	0.64%	83,350 -51,150	-38%	-$341K
30	RAPP 30 Rapport Therapeutics RAPP $365M	$164K	0.19%	16,400	–	–
31	31 Forte Biosciences FBRX $44.8M	$143K	0.17%	18,469 +330	+2%	+$2.56K
32	ARTV 32 Artiva Biotherapeutics, Inc. Common Stock ARTV $49.9M	$136K	0.16%	45,456 +1,456	+3%	+$4.37K
33	33 Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 NUVB.WS $79.6M	$17.5K	0.02%	90,832	–	–
34	34 Arcellx ACLX $3.21B	$0	0%	0 -10,743	Closed	–
35	35 Celcuity CELC $409M	$0	0%	0 -25,000	Closed	–
36	36 Crinetics Pharmaceuticals CRNX $2.9B	$0	0%	0 -122,900	Closed	–
37	37 Corvus Pharmaceuticals CRVS $300M	$0	0%	0 -74,307	Closed	–
38	38 Eledon Pharmaceuticals ELDN $174M	$0	0%	0 -235,750	Closed	–
39	39 Mersana Therapeutics MRSN $48.6M	$0	0%	0 -1,120,500	Closed	–
40	40 NewAmsterdam Pharma NAMS $2.11B	$0	0%	0 -50,000	Closed	–
41	41 Vaxcyte PCVX $4.72B	$0	0%	0 -45,000	Closed	–
42	42 Sangamo Therapeutics SGMO $122M	$0	0%	0 -740,000	Closed	–
43	43 Third Harmonic Bio THRD $232M	$0	0%	0 -49,800	Closed	–
44	44 Taysha Gene Therapies TSHA $502M	$0	0%	0 -884,244	Closed	–
45	TECX 45 Tectonic Therapeutic, Inc. Common Stock TECX $377M	$0	0%	0 -33,008	Closed	–